DK486988A - PYRIDYLETHANOLAMINES, THEIR PREPARATIONS AND MEDICINALS CONTAINING THE COMPOUNDS - Google Patents
PYRIDYLETHANOLAMINES, THEIR PREPARATIONS AND MEDICINALS CONTAINING THE COMPOUNDSInfo
- Publication number
- DK486988A DK486988A DK486988A DK486988A DK486988A DK 486988 A DK486988 A DK 486988A DK 486988 A DK486988 A DK 486988A DK 486988 A DK486988 A DK 486988A DK 486988 A DK486988 A DK 486988A
- Authority
- DK
- Denmark
- Prior art keywords
- acid addition
- addition salts
- pyridylethanolamines
- diastereomers
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Hydrogenated Pyridines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Pyridylethanolamines of the formula <IMAGE> in which R denotes a carboxymethoxy, carbomethoxymethoxy, ethoxycarbonylmethoxy or 2-hydroxyethoxy group, their optical isomers, their diastereomers and their acid addition salts. The novel compounds of the above formula I, their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have useful pharmacological properties, namely an effect on the metabolism, preferably a hypoglycaemic and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by processes which are known per se.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873729284 DE3729284A1 (en) | 1987-09-02 | 1987-09-02 | NEW HETEROARYLETHANOLAMINES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK486988D0 DK486988D0 (en) | 1988-09-01 |
| DK486988A true DK486988A (en) | 1989-03-03 |
Family
ID=6335037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK486988A DK486988A (en) | 1987-09-02 | 1988-09-01 | PYRIDYLETHANOLAMINES, THEIR PREPARATIONS AND MEDICINALS CONTAINING THE COMPOUNDS |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0305845B1 (en) |
| JP (1) | JPH0196172A (en) |
| KR (1) | KR890005056A (en) |
| AT (1) | ATE81851T1 (en) |
| AU (1) | AU617353B2 (en) |
| CA (1) | CA1331005C (en) |
| DE (2) | DE3729284A1 (en) |
| DK (1) | DK486988A (en) |
| FI (1) | FI884003A (en) |
| IL (1) | IL87620A0 (en) |
| NZ (1) | NZ226006A (en) |
| PT (1) | PT88392B (en) |
| ZA (1) | ZA886501B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4918086A (en) * | 1987-08-07 | 1990-04-17 | Ciba-Geigy Corporation | 1-nitro-2,2-diaminoethylene derivatives |
| DE4006794A1 (en) * | 1990-03-03 | 1991-09-05 | Bayer Ag | METHOD FOR PRODUCING AMINOETHANOL DERIVATIVES |
| AU2003248614B2 (en) * | 2002-07-17 | 2007-08-30 | Lek Pharmaceuticals D.D. | Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3615293A1 (en) * | 1986-05-06 | 1987-11-12 | Bayer Ag | USE OF HETEROARYLETHYLAMINE FOR PERFORMANCE IN ANIMALS, HETEROARYLETHYLAMINE AND METHOD FOR THE PRODUCTION THEREOF |
| CA1287061C (en) * | 1986-06-27 | 1991-07-30 | Roche Holding Ltd. | Pyridine ethanolamine derivatives |
| DE3627663A1 (en) * | 1986-08-14 | 1988-03-03 | Bayer Ag | HETEROARYLETHYLAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PERFORMANCE IN ANIMALS |
| DE3861031D1 (en) * | 1987-03-07 | 1990-12-20 | Bayer Ag | METHOD FOR PRODUCING 5-AMINO-4,6-DIHALOGENPYRIDINE. |
-
1987
- 1987-09-02 DE DE19873729284 patent/DE3729284A1/en not_active Withdrawn
-
1988
- 1988-08-22 EP EP88113612A patent/EP0305845B1/en not_active Expired - Lifetime
- 1988-08-22 AT AT88113612T patent/ATE81851T1/en not_active IP Right Cessation
- 1988-08-22 DE DE8888113612T patent/DE3875563D1/en not_active Expired - Fee Related
- 1988-08-31 IL IL87620A patent/IL87620A0/en unknown
- 1988-08-31 FI FI884003A patent/FI884003A/en not_active Application Discontinuation
- 1988-08-31 CA CA000576154A patent/CA1331005C/en not_active Expired - Fee Related
- 1988-08-31 NZ NZ226006A patent/NZ226006A/en unknown
- 1988-09-01 ZA ZA1988/06501A patent/ZA886501B/en unknown
- 1988-09-01 AU AU21790/88A patent/AU617353B2/en not_active Ceased
- 1988-09-01 PT PT88392A patent/PT88392B/en not_active IP Right Cessation
- 1988-09-01 JP JP63219623A patent/JPH0196172A/en active Pending
- 1988-09-01 KR KR1019880011275A patent/KR890005056A/en not_active Application Discontinuation
- 1988-09-01 DK DK486988A patent/DK486988A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT88392B (en) | 1992-10-30 |
| PT88392A (en) | 1989-07-31 |
| EP0305845A1 (en) | 1989-03-08 |
| ATE81851T1 (en) | 1992-11-15 |
| FI884003A0 (en) | 1988-08-31 |
| CA1331005C (en) | 1994-07-26 |
| DK486988D0 (en) | 1988-09-01 |
| NZ226006A (en) | 1991-05-28 |
| AU2179088A (en) | 1989-03-02 |
| JPH0196172A (en) | 1989-04-14 |
| EP0305845B1 (en) | 1992-10-28 |
| IL87620A0 (en) | 1989-01-31 |
| KR890005056A (en) | 1989-05-11 |
| DE3729284A1 (en) | 1989-03-23 |
| AU617353B2 (en) | 1991-11-28 |
| FI884003A (en) | 1989-03-03 |
| DE3875563D1 (en) | 1992-12-03 |
| ZA886501B (en) | 2008-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0742209A3 (en) | A process for producing an optically active quinolinemevalonolactone and a process for producing an optically active quinolinemevalonic acid salt | |
| FI883249A0 (en) | A process for the preparation of therapeutically useful 3-desmethylmevalonic acid derivatives | |
| PT80820B (en) | METHOD FOR PREPARING DERIVATIVES OF 2-SUBSTITUTED 1,3-PROPYLIDENODPHOSPHONATE | |
| PL263885A1 (en) | Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide | |
| SE8600017D0 (en) | NEW COMPOUND | |
| NO850216L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED 5,11-DIHYDRO-6-DIBENZ (B, E) -AZEPIN-6-ON DERIVATIVES | |
| FR2688506B1 (en) | PROCESS FOR THE PREPARATION OF SALTS OF CLAVULANIC ACID. | |
| DK486988A (en) | PYRIDYLETHANOLAMINES, THEIR PREPARATIONS AND MEDICINALS CONTAINING THE COMPOUNDS | |
| PT85901A (en) | Method of desinfecting soft contact lenses with a stabilized hidrogen peroxide solution and process for preparing said solution | |
| EP0157324A3 (en) | Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application | |
| DK0571243T3 (en) | Thiochromane derivatives, processes for their preparation, and pharmaceutical agents containing ice | |
| NO165393C (en) | PROCEDURE FOR THE PREPARATION OF ARYLOXYPROPANOLAMINES AND SALTS OF THESE WITH DIPHENYLEDIC ACETIC ACID. | |
| AU7826891A (en) | Heterocyclyl substituted 6-halopenem compounds | |
| FI913951A0 (en) | Process for the preparation of crystalline 7-amino-3- (5-carboxymethyl-4-methyl-1,3-thiazol-2-yl-thiomethyl) -ceph-3-em-4-carboxylic acid (TACS) | |
| DE3750117D1 (en) | Process for the preparation of indolinone-2 derivatives. | |
| ITMI911052A0 (en) | PROCESS FOR THE PREPARATION OF 2,4 -DICHLOROPHENOXYACETIC ACID | |
| PT88294A (en) | PROCESS FOR THE PREPARATION OF PHENANTRIDINE DERIVATIVES | |
| AU1099888A (en) | Novel imidazo- and triazolothiadiazines, a process for the preparation thereof, medicaments containing same, and the use thereof, and some intermediates formed in the preparation of the compounds mentioned | |
| ATE80629T1 (en) | BETA-LACTAM ANTIBIOTICS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS AND IN PHARMACEUTICALS. | |
| EP0301834A3 (en) | Derivatives of benzoyloxyacetic acid, and preparation and formulations thereof for therapeutic use | |
| CS934687A1 (en) | Method of cis-2,2-dimethyl-3-(2,2-dihalovinyl) cyclopropancarboxylic acid's optical isomers preparation | |
| DK43484A (en) | AZEPINO (1,2-A) PYRIMIDINE DERIVATIVES OR ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND USE AS SOURCE CHODILATORIC AGENTS | |
| IE870122L (en) | Treatment of coronary disease | |
| ATE200282T1 (en) | PRODUCTION OF AN EPOXY | |
| ITMI911094A0 (en) | PROCESS FOR THE PREPARATION OF 5(2,4 DIFLUOROPHENYL) SALICYLIC ACID |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |